No abstract available
Keywords: COVID-19; Haematological malignancies; SARS-CoV-2 infection; anti-CD20 monoclonal antibodies; obinutuzumab; rituximab.
All Keywords
【저자키워드】 COVID-19, SARS-COV-2 infection, haematological malignancies, obinutuzumab, rituximab., anti-CD20 monoclonal antibodies, 【초록키워드】 SARS-CoV-2, SARS-COV-2 infection, haematological malignancies, rituximab, obinutuzumab, anti-CD20, monoclonal, Abstract, 【제목키워드】 variant, outcome, omicron, Patient, diagnosed,
【저자키워드】 COVID-19, SARS-COV-2 infection, haematological malignancies, obinutuzumab, rituximab., anti-CD20 monoclonal antibodies, 【초록키워드】 SARS-CoV-2, SARS-COV-2 infection, haematological malignancies, rituximab, obinutuzumab, anti-CD20, monoclonal, Abstract, 【제목키워드】 variant, outcome, omicron, Patient, diagnosed,
사용 가능한 초록 없음
{{ 키워드: }} 코로나19; 혈액암; SARS-CoV-2 감염; 항-CD20 모노클로날 항체; 오비누투주맙; 리툭시맙.